Published in Cancer Weekly, October 17th, 2006
According to recent research from the United States, "Tumor recurrence is a hallmark of superficial bladder cancer. Currently, a molecular marker for bladder cancer recurrence is lacking."
"E-cadherin plays an important role in epithelial development and in the establishment and maintenance of cell-cell adhesion and tissue architecture," explained J. Lin and colleagues, M.D. Anderson Cancer Center. "The purpose of this study is to investigate the association of an E-cadherin promoter polymorphism with the risk of bladder cancer recurrence. This study...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Cancer Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.